Polycythemia - 31 Studies Found
| Completed |
: Study to Assess the Self-administration of AOP2014 Using a Pen, Developed for the Treatment of Polycythemia Vera Patients : Polycythemia Vera : 2015-06-12 : Drug: Pegylated-Proline-Interferon alpha-2b in a Pre-filled Pen Subjects will continue to receive the do |
| Completed |
: Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Are Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Are Available. : Polycythemia Vera : 2014-11-05 : Drug: Ruxolitinib |
| Active, not recruiting |
: AOP2014 vs. BAT in Patients With Polycythemia Vera Who Previously Participated in the PROUD-PV Study. : Polycythemia Vera : 2014-08-14 :
|
| Completed |
: Treatment of Polycythemia Vera With Gleevec : Polycythemia Vera : 2010-05-07 : Drug: Gleevec 400 mg once daily for 12 months Other |
| Completed |
: Effects of Imatinib Mesylate in Polycythemia Vera : Polycythemia Vera : 2007-01-31 : Drug: Imatinib Mesylate 400 mg/die for 6 months |
| Active, not recruiting |
: Ruxolitinib Efficacy and Safety in Patients With HU Resistant or Intolerant Polycythemia Vera vs Best Available Therapy. : Polycythemia Vera : 2014-01-14 :
|
| Terminated |
: Trial of Erlotinib in Patients With JAK-2 V617F Positive Polycythemia Vera : Polycythemia Vera : 2009-12-22 : Drug: Erlotinib Erlotinib supplied as tablets; oral dose of erlotinib of 150 mg daily to be continued fo |
| Completed |
: Pegylated Interferon Alpha-2b Versus Hydroxyurea in Polycythemia Vera : Polycythemia Vera : 2013-09-06 :
|
| Active, not recruiting |
: Safety Study of Pegylated Interferon Alpha 2b to Treat Polycythemia Vera : Polycythemia Vera : 2010-09-01 : Drug: PEG-P-INF alpha-2b (P1101) µg (starting with 50 µg), subcutaneously, 2-weekly administra |
| Withdrawn |
: Clopidogrel and Aspirin for the Treatment of Polycythemia Vera : Polycythemia Vera : 2009-07-14 :
|